These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6187698)

  • 1. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VI. Occasional escape from host rejection due to antigen-loss secondary variants.
    Maryanski JL; Marchand M; Uyttenhove C; Boon T
    Int J Cancer; 1983 Jan; 31(1):119-23. PubMed ID: 6187698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones.
    Maryanski JL; Boon T
    Eur J Immunol; 1982 May; 12(5):406-12. PubMed ID: 6178608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VII. Dominant expression of variant antigens in somatic cell hybrids.
    Maryanski JL; Szpirer J; Szpirer C; Boon T
    Somatic Cell Genet; 1983 May; 9(3):345-57. PubMed ID: 6407125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice.
    Uyttenhove C; Van Snick J; Boon T
    J Exp Med; 1980 Nov; 152(5):1175-83. PubMed ID: 6776226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.
    Boon T; Van Snick J; Van Pel A; Uyttenhove C; Marchand M
    J Exp Med; 1980 Nov; 152(5):1184-93. PubMed ID: 6776227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression.
    Uyttenhove C; Maryanski J; Boon T
    J Exp Med; 1983 Mar; 157(3):1040-52. PubMed ID: 6187879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response.
    Maryanski JL; Van Snick J; Cerottini JC; Boon T
    Eur J Immunol; 1982 May; 12(5):401-6. PubMed ID: 6178607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. V. H-2 associativity of variant-specific antigens.
    Van Snick J; Maryanski J; Van Pel A; Parmiani G; Boon T
    Eur J Immunol; 1982 Nov; 12(11):905-8. PubMed ID: 6818041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assay.
    Wölfel T; Van Pel A; De Plaen E; Lurquin C; Maryanski JL; Boon T
    Immunogenetics; 1987; 26(3):178-87. PubMed ID: 3114137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour cell variants with increased immunogenicity obtained by mutagen treatment.
    Boon T; Maryanski J
    Cancer Surv; 1985; 4(1):135-48. PubMed ID: 3879855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the gene of tum- transplantation antigen P35B: presence of a point mutation in the antigenic allele.
    Szikora JP; Van Pel A; Brichard V; André M; Van Baren N; Henry P; De Plaen E; Boon T
    EMBO J; 1990 Apr; 9(4):1041-50. PubMed ID: 2108859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased frequency of immunogenic variants obtained by repeated mutagen treatment of mouse mastocytoma P815.
    Marchand M; Caspar P; Boon T
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1529-37. PubMed ID: 6196202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation.
    De Plaen E; Lurquin C; Van Pel A; Mariamé B; Szikora JP; Wölfel T; Sibille C; Chomez P; Boon T
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2274-8. PubMed ID: 3127830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenic variants obtained by mutagenesis of mouse Lewis lung carcinoma. Recognition of variant-specific antigens by cytolytic T lymphocytes.
    Vessière F; Georlette M; Warnier G; Leclerc JC; Van Pel A; Boon T
    Eur J Cancer Clin Oncol; 1982 Sep; 18(9):867-74. PubMed ID: 6185345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent T cell receptor rearrangements in the cytotoxic T lymphocyte response in vivo against the p815 murine tumor.
    Levraud JP; Pannetier C; Langlade-Demoyen P; Brichard V; Kourilsky P
    J Exp Med; 1996 Feb; 183(2):439-49. PubMed ID: 8627157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice.
    Van den Eynde B; Lethé B; Van Pel A; De Plaen E; Boon T
    J Exp Med; 1991 Jun; 173(6):1373-84. PubMed ID: 1903428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization.
    Gajewski TF; Fallarino F; Uyttenhove C; Boon T
    J Immunol; 1996 Apr; 156(8):2909-17. PubMed ID: 8609411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide.
    Sibille C; Chomez P; Wildmann C; Van Pel A; De Plaen E; Maryanski JL; de Bergeyck V; Boon T
    J Exp Med; 1990 Jul; 172(1):35-45. PubMed ID: 1694221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide.
    Lethé B; van den Eynde B; van Pel A; Corradin G; Boon T
    Eur J Immunol; 1992 Sep; 22(9):2283-8. PubMed ID: 1381312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.